{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T01:01:07Z","timestamp":1783472467533,"version":"3.55.0"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,5,1]]},"DOI":"10.2146\/ajhp130485","type":"journal-article","created":{"date-parts":[[2014,4,14]],"date-time":"2014-04-14T20:50:52Z","timestamp":1397508652000},"page":"717-721","source":"Crossref","is-referenced-by-count":6,"title":["Nalbuphine-induced psychosis treated with naloxone"],"prefix":"10.1093","volume":"71","author":[{"given":"Laura A.","family":"Siemianowski","sequence":"first","affiliation":[{"name":"Philadelphia College of Pharmacy, University of the Sciences, Philadelphia, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin P.","family":"Rosenheck","sequence":"additional","affiliation":[{"name":"Cooper University Hospital, Camden, NJ."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig B.","family":"Whitman","sequence":"additional","affiliation":[{"name":"Barnes Jewish Hospital, St. Louis, MO."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","reference":[{"key":"2019041211002786200_b1-0710717","volume-title":"Nubain (nalbuphine hydrochloride) prescribing information","year":"2005"},{"key":"2019041211002786200_b2-0710717","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/00003643-200106000-00002","article-title":"Pharmacological control of opioid-induced pruritus: a quantitative systematic review of randomized trials","volume":"18","author":"Kjellberg","year":"2001","journal-title":"Eur J Anaesthesiol"},{"key":"2019041211002786200_b3-0710717","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1097\/00000539-200107000-00032","article-title":"Nalbuphine versus propofol for treatment of intrathecal morphine-induced pruritus after cesarean delivery","volume":"93","author":"Charuluxananan","year":"2001","journal-title":"Anesth Analg"},{"key":"2019041211002786200_b4-0710717","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1447-0756.1999.tb01149.x","article-title":"Optimal dose of nalbuphine for treatment of intrathecal morphine-induced pruritus after cesarean section","volume":"25","author":"Somrat","year":"1999","journal-title":"J Obstet Gynaecol Res"},{"key":"2019041211002786200_b5-0710717","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1213\/00000539-199211000-00016","article-title":"Nalbuphine is better than naloxone for treatment of side effects after epidural morphine","volume":"75","author":"Cohen","year":"1992","journal-title":"Anesth Analg"},{"key":"2019041211002786200_b6-0710717","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1007\/BF03019227","article-title":"Treatment of intrathecal morphine-induced pruritus following cesarean section","volume":"44","author":"Alhashemi","year":"1997","journal-title":"Can J Anaesth"},{"key":"2019041211002786200_b7-0710717","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/00000542-198608000-00017","article-title":"Nalbuphine augmentation of analgesia and reversal of side effects following epidural hydromorphone","volume":"65","author":"Henderson","year":"1986","journal-title":"Anesthesiology"},{"key":"2019041211002786200_b8-0710717","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/BF03020347","article-title":"Reversal of epidural morphine-induced respiratory depression and pruritus with nalbuphine","volume":"35","author":"Penning","year":"1988","journal-title":"Can J Anaesth"},{"key":"2019041211002786200_b9-0710717","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.acpain.2004.02.002","article-title":"Use of the mixed agonist-antagonist nalbuphine in opioid-based analgesia","volume":"6","author":"Gunion","year":"2004","journal-title":"Acute Pain"},{"key":"2019041211002786200_b10-0710717","volume-title":"Duramorph (morphine sulfate) prescribing information","year":"2010"},{"key":"2019041211002786200_b11-0710717","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.2165\/00003495-200767160-00003","article-title":"Pathophysiology and management of opioid-induced pruritus","volume":"67","author":"Ganesh","year":"2007","journal-title":"Drugs"},{"key":"2019041211002786200_b12-0710717","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1097\/00000542-199711000-00011","article-title":"Opioid-sparing effects of a low-dose infusion of naloxone in patient-administered morphine sulfate","volume":"87","author":"Gan","year":"1997","journal-title":"Anesthesiology"},{"key":"2019041211002786200_b13-0710717","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1345\/aph.10121","article-title":"Opioid antagonists in the treatment of opioid-induced constipation and pruritus","volume":"35","author":"Friedman","year":"2001","journal-title":"Ann Pharmacother"},{"key":"2019041211002786200_b14-0710717","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1056\/NEJM200108093450618","article-title":"\u201cInvisible\u201d synthetic opiates and acute psychosis","volume":"345","author":"Camacho","year":"2001","journal-title":"N Engl J Med"},{"key":"2019041211002786200_b15-0710717","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/CCM.0b013e3182783b72","article-title":"Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit","volume":"41","author":"Barr","year":"2013","journal-title":"Crit Care Med"},{"key":"2019041211002786200_b16-0710717","volume-title":"Diagnostic and statistical manual","author":"American Psychiatric Association","year":"1994","edition":"4th ed"},{"key":"2019041211002786200_b17-0710717","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1007\/s00296-013-2750-z","article-title":"Corticosteroid-induced neuropsychiatric disorders: review and contrast with neuropsychiatric lupus","volume":"33","author":"Bhangle","year":"2013","journal-title":"Rheumatol Int"},{"key":"2019041211002786200_b18-0710717","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1345\/aph.1A440","article-title":"Metoclopramide-induced supersensitivity psychosis","volume":"36","author":"Lu","year":"2002","journal-title":"Ann Pharmacother"},{"key":"2019041211002786200_b19-0710717","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1684\/j.1950-6945.2003.tb00573.x","article-title":"Acute psychosis associated with levetiracetam","volume":"5","author":"Youroukos","year":"2003","journal-title":"Epileptic Disord"},{"key":"2019041211002786200_b20-0710717","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1212\/01.WNL.0000078031.32904.0D","article-title":"Psychiatric adverse events during levetiracetam therapy","volume":"61","author":"Mula","year":"2003","journal-title":"Neurology"},{"key":"2019041211002786200_b21-0710717","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1177\/070674370404901222","article-title":"Drug-induced psychosis after long-term treatment with levetiracetam","volume":"49","author":"Bayerlein","year":"2004","journal-title":"Can J Psychiatry"},{"key":"2019041211002786200_b22-0710717","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.yebeh.2005.04.016","article-title":"Catatonia induced by levetiracetam","volume":"8","author":"Chouinard","year":"2006","journal-title":"Epilepsy Behav"},{"key":"2019041211002786200_b23-0710717","doi-asserted-by":"crossref","first-page":"E19","DOI":"10.1176\/jnp.23.3.jnpe19","article-title":"Probable psychosis associated with levetiracetam: a case report","volume":"22","author":"Aggarwal","year":"2011","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"2019041211002786200_b24-0710717","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1001\/archinte.161.17.2091","article-title":"Cognitive and other adverse effects of diphenhydramine use in hospitalized older patients","volume":"161","author":"Agostini","year":"2001","journal-title":"Arch Intern Med"},{"key":"2019041211002786200_b25-0710717","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1001\/jama.1996.03530350034031","article-title":"Precipitating factors for delirium in hospitalized elderly persons. Predictive model and interrelationship with baseline vulnerability","volume":"275","author":"Inouye","year":"1996","journal-title":"JAMA"},{"key":"2019041211002786200_b26-0710717","volume-title":"Duragesic (fentanyl transdermal system) prescribing information","year":"2009"},{"key":"2019041211002786200_b27-0710717","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1097\/00003246-199804000-00015","article-title":"Acute withdrawal syndrome related to the administration of analgesic and sedative medications in adult intensive care unit patients","volume":"26","author":"Cammarano","year":"1998","journal-title":"Crit Care Med"},{"key":"2019041211002786200_b28-0710717","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0022-3565(25)24168-4","article-title":"Antagonist effects of nalbuphine in opioid-dependent healthy volunteers","volume":"248","author":"Preston","year":"1989","journal-title":"J Pharmacol Exp Ther"},{"key":"2019041211002786200_b29-0710717","volume-title":"Narcan (naloxone hydrochloride) prescribing information","year":"2007"},{"key":"2019041211002786200_b30-0710717","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1177\/026921630501900218","article-title":"Caution with nalbuphine in patients on long-term opioids","volume":"19","author":"Hartree","year":"2005","journal-title":"Palliat Med"},{"key":"2019041211002786200_b31-0710717","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1111\/j.1365-2044.1992.tb03182.x","article-title":"Nalbuphine\u2014an analgesic with unique built-in safety feature","volume":"47","author":"Nandakumar","year":"1992","journal-title":"Anaesthesia"},{"key":"2019041211002786200_b32-0710717","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajhp\/article-pdf\/71\/9\/717\/28372543\/ajhp0717.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T11:00:13Z","timestamp":1746183613000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/71\/9\/717\/5111264"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,1]]},"references-count":32,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014,5,1]]}},"URL":"https:\/\/doi.org\/10.2146\/ajhp130485","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2014,5,1]]},"published":{"date-parts":[[2014,5,1]]}}}